Our research focuses on the development of novel Magnetic Resonance Imaging (MRI) acquisition and reconstruction methods with an emphasis on the extraction of quantitative imaging biomarkers. The developed methods are being translated into clinical studies for improving the diagnosis, the therapy monitoring, and the understanding of disease pathophysiology in diseases of the musculoskeletal system (e.g. osteoporosis, neuropathies, neuromuscular diseases), in metabolic dysfunction (e.g. obesity, diabetes, cachexia) and in body oncology.
Our research is performed on two 3 Tesla Ingenia MR scanners (Philips Healthcare, Best, NL). We are working closely with radiologists from the Department of Radiology, the Department of Neuroradiology and the Department of Nuclear Medicine at TUM. We also enjoy collaborations with research groups in the TUM Institute of Medical Engineering (IMETUM), the TUM Else Kröner Fresenius Center for Nutritional Medicine, the TUM Chair of Biological Imaging, the TUM Chair of Biomedical Physics, the TUM Department of Computer Science, the TUM Department of Sport and Health Sciences, the TUM Chair of Analytical Food Chemistry and the Institute for Diabetes and Cancer in Helmholtz Zentrum München.
We share our developed MRI techniques with other academic institutions and actively participate in international collaborations with research groups in the University of California San Francisco (UCSF), the Phoenix’s Children Hospital, the University of Texas Southwestern Medical Center and the University Hospital of Lille.
For many of our technical developments, we work in close collaboration with scientists from Philips Healthcare Clinical Science (Hamburg, DE and Best, NL) and from the Philips Research Laboaratories (Hamburg, DE).
We are grateful to the research support from a wide range of organizations.